CU Gynecologic Oncology Winter/Spring 2025 Newsletter
Event Recap
Thriving Together: Gynecologic Cancer Survivorship and Beyond
The Thriving Together: Gynecologic Cancer Survivorship and Beyond conference was hosted by the CU Division of Gynecology Oncology and the Colorado Gynecologic Cancer Alliance (CGCA) on Friday, January 10th, 2025, at the University of Colorado Anschutz Health Sciences Building (AHSB). The event connected patients, survivors, caregivers, and loved ones to support, resources, and community. About 125 individuals joined for a day of learning, discussion, and questions. Navigating gynecologic cancers during and after treatment is challenging, but you don’t have to do it alone. Let’s continue to thrive together!
Grant Updates
Benjamin Bitler, PhD, an Associate Professor in the Division of Reproductive Sciences, and Edward Chuong, PhD, an Assistant Professor at CU Boulder’s BioFrontiers Institute, have been awarded a grant from the Department of Defense (DOD) assessing therapy-resistant ovarian cancer.
Levi Watson, PhD, an Assistant Professor in the Division of Reproductive Sciences, has been awarded a “SCORE Scholarship” from the Colorado Specialized Center of Research Excellence (SCORE) on Sex Differences (U54 AG062319) focused on Bioenergetic and Cardiometabolic Consequences of the Loss of Gonadal Function.
Taylor Benson, PhD, a Postdoctoral Research Fellow at the University of Colorado Anschutz Medical Campus, was awarded the HERA Ovarian Cancer Foundation’s “Outside-the-Box” grant to study WNT4-driven metabolic remodeling for early detection of ovarian clear cell carcinoma (OCCC). This research, funded in memory of Anne Emery Kyllo, explores how a common genetic variant increases WNT4 production, raising ovarian cancer risk, particularly in East Asian populations.
Upcoming Event
Jodi’s Race
Join the University of Colorado Division of Gynecologic Oncology and the Colorado Gynecologic Cancer Alliance (CGCA) at City Park for the 16th Annual Jodi’s Race for Awareness on Saturday, June 14th, 2025. Join us in honoring the strength of women who have bravely battled—and continue to fight—gynecologic cancer, while also spreading vital awareness about this important cause!! We invite you to stop by the CU Gynecologic Oncology booth, where our staff, researchers, and physicians will be available to answer questions and provide valuable awareness information.
Event Date: Saturday, June 14, 2025
Location: Denver’s City Park
Registration:jodisrace.org
CU Medicine Gynecologic Oncology – Broomfield & Lakewood Celebrate Opening
We are thrilled to announce the expansion of our Gynecologic Oncology practice in Colorado to Broomfield and Lakewood.Carolyn Lefkowits, MD, MPH, MS, will practice at the Broomfield location, while continuing her role at the University of Colorado Cancer Center. Jill Alldredge, MD, will practice at the Lakewood location and will continue seeing patients at CU Medicine Gynecologic Oncology – Highlands Ranch Specialty Care Center and UCHealth Gynecologic Oncology Clinic – Anschutz Medical Campus.
We launched the CU Ovarian Cancer Innovations Group (OCIG) in October 2023, and we are excited to announce the new CU OCIG website! Our new site features comprehensive information about OCIG’s mission, vision, and leadership, along with insights into our diverse research initiatives including Basic Science, Translational, Clinical, and Community Research. Visit our new website today!
Congratulations to Lindsay Brubaker, MD, Assistant Professor in the Division of Gynecologic Oncology on being awarded the LeBert-Seuss Family Professorship in Ovarian Cancer Research. Having been deeply affected by ovarian cancer within their extended family, The Lebert-Seuss family hopes this endowed professorship will reduce the disease’s impact on others by funding groundbreaking research that could transform the future for those affected, lessening suffering for families for years to come.
Faculty Profile: Bradley Corr, MD
Bradley Corr, MD, is an associate professor and gynecologic oncologist with a passion for clinical trials. He is married with two children and two dogs. He grew up in the New York area and went to undergraduate school at Middlebury College. He later attended medical school at Vanderbilt University and his OB-GYN residency at the University of Pennsylvania. He completed his fellowship in Gynecologic Oncology at the University of Colorado and has been on the faculty since then. He was the inaugural recipient of the LeBert-Suess Family Endowed Professorship in Ovarian Cancer Research from 2022 through 2024, and in 2024 became the inaugural recipient of the Katie Taylor Memorial Endowed Chair in Gynecologic Oncology.
Dr. Corr serves as the Director of clinical research for the Division of Gynecologic Oncology. He is the lead Gynecologic Oncologist for the women’s cancer developmental therapeutics program as well as the lead gynecologic oncologist for the phase I division at the University of Colorado. Nationally he serves as the vice chair for the phase I committee of the NRG and has sat on multiple review and strategy planning committees for the FDA and NCI.
His research is focused on developmental therapeutics in ovarian and endometrial cancers. He holds multiple funding sources including a current federally funded R01 grant evaluating combination Wnt and PARP inhibition in platinum-resistant ovarian cancer. He has developed strong collaborations to become a physician-scientist also developing the preclinical work to bring these therapies to patients in the clinic. Additionally, he is an internationally recognized clinical trialist who is leading multiple local, national, and international clinical trials in ovarian and uterine cancers.
Dr. Corr is passionate about advancing the therapeutic options for patients and families dealing with gynecologic malignancies. He believes strongly in developing clinical trials that will hopefully lead to advancements in our care options. He believes every person’s care plan should include the consideration of clinical trial if it is right for them.
